Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
In recent years, conventional treatments including surgery, chemotherapy and radiotherapy
have been the main approaches in tumour therapy. Cancer immunotherapy is a new …
have been the main approaches in tumour therapy. Cancer immunotherapy is a new …
[HTML][HTML] Polysaccharide-based nanomedicines for cancer immunotherapy: A review
Cancer immunotherapy is an effective antitumor approach through activating immune
systems to eradicate tumors by immunotherapeutics. However, direct administration of …
systems to eradicate tumors by immunotherapeutics. However, direct administration of …
Click-reaction-mediated chemotherapy and photothermal therapy synergistically inhibit breast cancer in mice
G Zhang, X Chen, X Chen, K Du, K Ding, D He… - ACS …, 2023 - ACS Publications
The development of functional materials for tumor immunogenicity enhancement is
desirable for overcoming the low therapeutic efficiency and easy metastasis during tumor …
desirable for overcoming the low therapeutic efficiency and easy metastasis during tumor …
mRNA-based cancer vaccines: a therapeutic strategy for the treatment of melanoma patients
M Bidram, Y Zhao, NG Shebardina, AV Baldin… - Vaccines, 2021 - mdpi.com
Malignant melanoma is one of the most aggressive forms of cancer and the leading cause of
death from skin tumors. Given the increased incidence of melanoma diagnoses in recent …
death from skin tumors. Given the increased incidence of melanoma diagnoses in recent …
TCR redirected T cells for cancer treatment: achievements, hurdles, and goals
F Manfredi, BC Cianciotti, A Potenza, E Tassi… - Frontiers in …, 2020 - frontiersin.org
Adoptive T cell therapy (ACT) is a rapidly evolving therapeutic approach designed to
harness T cell specificity and function to fight diseases. Based on the evidence that T …
harness T cell specificity and function to fight diseases. Based on the evidence that T …
Immune checkpoint inhibitors in cancer therapy—how to overcome drug resistance?
Y Lao, D Shen, W Zhang, R He, M Jiang - Cancers, 2022 - mdpi.com
Simple Summary Immune checkpoint inhibitors (ICIs) are an important strategy in cancer
therapy. However, with the widespread clinical use of ICIs, people gradually found that ICIs …
therapy. However, with the widespread clinical use of ICIs, people gradually found that ICIs …
Metal-based nano-vaccines for cancer immunotherapy
J Li, H Ren, Y Zhang - Coordination Chemistry Reviews, 2022 - Elsevier
Cancer vaccination is an effective way to prevent or cure cancers by inducing strong cellular
and humoral immunity with the aid of delivery carriers or adjuvants. Increasing new delivery …
and humoral immunity with the aid of delivery carriers or adjuvants. Increasing new delivery …
Evolution and progress of mRNA vaccines in the treatment of melanoma: future prospects
mRNA vaccines encoding tumor antigens may be able to sensitize the immune system of the
host against cancer cells, enhancing antigen presentation and immune response. Since the …
host against cancer cells, enhancing antigen presentation and immune response. Since the …
[HTML][HTML] Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
Q Zhou, X Yan, H Zhu, Z **n, J Zhao, W Shen, W Yin… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Diffuse glioma patients have high mortality and recurrence despite multimodal
therapies. This study aims to identify the potential tumor antigens for mRNA vaccines and …
therapies. This study aims to identify the potential tumor antigens for mRNA vaccines and …
Cell surface sphingomyelin: Key role in cancer initiation, progression, and immune evasion
Cell surface biochemical changes, notably excessive increase in outer leaflet sphingomyelin
(SM) content, are important in cancer initiation, growth, and immune evasion. Innumerable …
(SM) content, are important in cancer initiation, growth, and immune evasion. Innumerable …